NCT07301658Completed
Efficacy and Safety of Revodiol Calming Cream® in Atopic Dermatitis.
Evaluation of the Effectiveness and Safety of Revodiol Calming Cream® in the Management of Atopic Dermatitis Under Dermatological Control.
Source: ClinicalTrials.gov · Last updated 24 Dec 2025
Brief summary (registry, in English)
A 56-day clinical study evaluated Revodiol Calming Cream on pediatric and adult participants with mild to moderate atopic-prone skin under dermatological supervision. The product was applied twice daily, and efficacy was assessed through dermatological scoring, instrumental measurements, and subjective questionnaires. Results aimed to show improvements in barrier function, hydration, skin texture, and reduction of erythema, dryness, and pruritus, with feedback on comfort and quality of life.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 42 (actual)
- First submitted
- 27 Nov 2025
- Start date
- 27 Feb 2023
- Primary completion date
- 6 Jun 2023
- Lead sponsor
- i+Med S.Coop.
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT07301658
What you commit to
- Study type: Interventional
- Participants enrolled: 42
- From 27 Feb 2023 to the primary completion date, 6 Jun 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Recent surgery or treatments in the study area.
- Use of antihistamines and antibiotics within 15 days prior to the start of the study.
- Treatment with antihistamines, antibiotics, corticosteroids, immunosuppressants or completion of such treatment within 15 days prior to the start of the study.
Other illness
- History of allergies to cosmetic products.
Other
- Oncology patients.
- Use of any other product for dermatitis during the study.
- Sun exposure or UVA rays during the study.
- Participation in another clinical study.
- Health problems that may compromise adherence to the study protocol.
Who the study is looking for
- Sex: both.
- Age: from 0 months onwards (includes children and adults).
- Atopic-prone skin.
- Mild to moderate flare-up.
- Skin dryness.
- Signed informed consent (by the volunteer or legal guardian as applicable).
- Adequate understanding of the clinical study by the participant or legal guardian.
- Good physical and psychological health.
- No application of any product on the experimental area on the first day of the trial.
- Availability to guarantee visits to the research center.
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| i+Med S.Coop. Coordinator of this site? Confirm its status | Vitoria-Gasteiz | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.